CHUGAI PHARMABODY RESEARCH
Chugai Pharmabody Research provides drug discovery research by creating new antibody-drug clinical candidates.
CHUGAI PHARMABODY RESEARCH
Industry:
Biopharma Biotechnology Health Care
Founded:
2012-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.chugai-pharmabody.com
Total Employee:
101+
Status:
Active
Contact:
65-6933-4888
Current Employees Featured
Official Site Inspections
http://www.chugai-pharmabody.com
- Host name: mail.benmart.com.sg
- IP address: 43.229.85.178
- Location: Singapore Singapore
- Latitude: 1.2929
- Longitude: 103.8547
- Timezone: Asia/Singapore
- Postal: 18
More informations about "Chugai Pharmabody Research"
About – Chugai Pharmabody Research
Chugai Pharmabody Research (CPR) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd. (“Chugai”), Japan’ s No.1 biopharmaceutical company, a member of Roche group, in January 2012 and …See details»
Overseas Group Companies | Chugai Group | Company …
+886- (0)2-2715-2000 Activities: Import, sales, clinical development and regulatory affairs for pharmaceutical products in Taiwan. Chugai Pharmabody Research Pte. Ltd. 3 Biopolis Drive, #07 - 11 to 16, Synapse, Singapore …See details»
CHUGAI PHARMABODY RESEARCH PTE. LTD. (201135838E)
Dec 16, 2011 CHUGAI PHARMABODY RESEARCH PTE. LTD. (the "Company") is a Private Company Limited by Shares, incorporated on 16 December 2011 (Friday) in Singapore . The …See details»
Japan's Chugai to position Singapore subsidiary as permanent …
Feb 5, 2024 Chugai Pharmaceutical has decided to position its research subsidiary in Singapore, Chugai Pharmabody Research (CPR) as a permanent global drug discovery …See details»
Chugai Pharmabody Research Company Profile - Craft
See insights on Chugai Pharmabody Research including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Company Profile – Chugai Pharmabody Research
Jul 2, 2021 Chugai Pharmabody Research (CPR) was established in Singapore as a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd. (“Chugai”), Japan’ s No.1 …See details»
Chugai Pharmabody Research - Crunchbase Company Profile
Chugai Pharmabody Research provides drug discovery research by creating new antibody-drug clinical candidates.See details»
Chugai - A*STAR Joint Development Project for Anti-Dengue Virus ...
Mar 30, 2017 Overseas, Chugai Pharmabody Research based in Singapore is engaged in research focusing on the generation of novel antibody drugs by utilizing Chugai’s proprietary …See details»
Chugai Pharmabody Research – Chugai Pharmabody
Chugai Pharmabody Research Pte. Ltd. takes great care over the information presented on this website, but it does not guarantee its accuracy, completeness, usefulness, etc.See details»
Meet Our CEO – Chugai Pharmabody Research
At Chugai Pharmabody Research (CPR) our drug discovery efforts are driven by our mission to advance patient-centric healthcare. As a core research institute of Chugai Pharmaceutical, a …See details»
Research Division – Chugai Pharmabody Research
Research Division Our research units are crucial in antibody research and drug discovery, which they achieve with practices of high caliber.See details»
Principal Scientist - Chugai Pharmabody Research - LinkedIn
Chugai Pharmabody Research Pte. Ltd. - Principal Scientist · Initiated career as a researcher of DMPK in Chugai Pharmaceutical in 2015. Dedicated to drug discovery and development of …See details»
Chugai Pharmabody Research Pte. Ltd. (Singapore) - EMIS
Sep 30, 2024 Chugai Pharmabody Research Pte. Ltd. is an enterprise in Singapore, with the main office in Singapore. The company operates in the Research and Development in …See details»
Advancing Antibody Research – Asian Scientist Magazine
Feb 4, 2020 Advancing Antibody Research Powerful antibody engineering technologies and a culture of collaboration set Chugai Pharmabody Research apart, says CEO Dr. Tomoyuki …See details»
CHUGAI PHARMABODY RESEARCH PTE. LTD. - app.sgpgrid.com
May 28, 2025 Chugai Pharmabody Research (CPR) is a subsidiary of Chugai Pharmaceutical in Japan, a member of Roche group, dedicated to addressing unmet medical needs through …See details»
Chugai and GSK Sign Collaboration Agreement for Anti-Dengue …
Jan 30, 2025 The anti-dengue virus antibody joint development project to overcome dengue fever, one of the "Neglected Tropical Diseases (NTDs)" as defined by the World Health …See details»
Company Outline | About Chugai | CHUGAI PHARMACEUTICAL …
Company Outline Company Profile This business overview includes a profile of Chugai's subsidiaries and affiliates. Business Processes The business processes that Chugai uses to …See details»
High-Throughput Innovation: How Chugai Pharmaceutical
Dr. Meiri Kawazoe, Chugai Pharmaceutical Co., Ltd. -How are you involved in the development of antibody drugs? I have a lot of experience with physical and chemical analysis experiments, …See details»
Chugai to Make Singapore Unit a Permanent Drug Discovery …
Feb 2, 2024 Chugai Pharmaceutical said on February 1 that it will be positioning its Singapore-based research subsidiary Chugai Pharmabody Research (CPR) as a permanent global drug …See details»
News – Chugai Pharmabody Research
May 13, 2025 News Browse through the latest news and developments by CPR and the Chugai Group.See details»